APOTHECOM ASSOCIATES LLC ANNOUNCES OPENING OF APOTHECOM EUROPE
New Office Located in London
LONDON UK, — March 3, 2003 — ApotheCom Associates LLC, a full-service health care communications company based in the United States, today announced the opening of its new European office in London, UK. The office will be managed by David Avitabile, who joins ApotheCom from Oxford Clinical Communications (OCC) Europe where he was director of business development. David has more than 15 years of experience in medical communications, including medical education, public relations, and business development.
"ApotheCom is an exciting, rapidly growing company that already has experienced tremendous success in the United States. I am very pleased to join such a dynamic organization," said David Avitabile. "With a strong existing client base, a huge opportunity exists to continue providing high-quality medical communications services to companies with global drug development and marketing teams located in Europe," added Avitabile.
"Our clients are now developing products worldwide, with global development plans culminating in simultaneous registration and launch in Europe, the United States, and Japan," comments ApotheCom President and CEO Neil Matheson. "The new European office has been established to respond to our clients' needs in terms of global medical communications programs to support successful commercialization," added Matheson.
ApotheCom Associates LLC is a full-service medical communications company providing advocacy development, publications planning, and medical education services to the pharmaceutical, biotechnology, and medical device industries. Founded in September 1999 by Neil Matheson and Lawrence Lesser, ApotheCom employs more than 135 people worldwide.
Contacts:
Neil W. Matheson
President & CEO
ApotheCom Associates LLC
Phone: (215) 550-8302
neil.matheson@apothecom.com
www.apothecom.com
David Avitabile
Managing Director
ApotheCom Europe
Phone: +44-(0)-20-8735-8101
david.avitabile@apothecom.com
www.apothecom.com
back to press releases main page
back to top
